MAGENTA THERAPEUTICS INC (MGTA) Forecast, Price Target & Analyst Ratings

NASDAQ:MGTA • US55910K1088

Current stock price

0.6996 USD
-0.06 (-7.74%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MAGENTA THERAPEUTICS INC (MGTA).

Forecast Snapshot

Consensus Price Target

Price Target
$1.02
+ 45.80% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 1, 2023
Period
Q3 / 2023
EPS Estimate
-$0.31
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$1.02
Upside
+ 45.80%
From current price of $0.70 to mean target of $1.02, Based on 6 analyst forecasts
Low
$1.01
Median
$1.02
High
$1.05

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for MGTA. The average price target is 1.02 USD. This implies a price increase of 45.8% is expected in the next year compared to the current price of 0.6996.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

MGTA Current Analyst RatingMGTA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

MGTA Historical Analyst RatingsMGTA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
MGTA was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about MGTA.
In the previous month the buy percentage consensus was at a similar level.
MGTA was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-02-28HC Wainwright & Co.Initiate Neutral
2023-01-26BTIGDowngrade Buy -> Neutral
2023-01-26Cowen & Co.Downgrade Outperform -> Market Perform
2023-01-26WedbushDowngrade Outperform -> Neutral
2022-12-21BTIGMaintains Buy
2022-08-25Goldman SachsDowngrade Buy -> Neutral
2022-05-24Goldman SachsMaintains Buy
2022-04-18MizuhoMaintains Buy
2022-04-18BTIGMaintains Buy
2022-01-24B. Riley SecuritiesMaintains Buy
2022-01-06Goldman SachsUpgrade Neutral -> Buy
2021-08-03JP MorganDowngrade Overweight -> Neutral
2021-06-29Cantor FitzgeraldInitiate Overweight
2021-06-15BTIGInitiate Buy
2021-05-18B. Riley SecuritiesInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 1, 2023
Period
Q3 / 2023
EPS Estimate
-$0.31
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-13.33%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
-100.00%

Next Earnings Summary

MGTA is expected to report earnings on 11/1/2023. The consensus EPS estimate for the next earnings is -0.31 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
MGTA revenue by date.MGTA revenue by date.
N/AN/AN/AN/AN/AN/A
184.60%		N/A
55.26%		N/A
32.09%
EBITDA
YoY % growth
MGTA ebitda by date.MGTA ebitda by date.
-9.26M-35.347M
-281.72%		-59.083M
-67.15%		-81.129M
-37.31%		-76.722M
5.43%		-72.672M
5.28%		-78.977M
-8.68%		N/A
11.62%		N/A
-13.18%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
MGTA ebit by date.MGTA ebit by date.
-9.27M-35.727M
-285.40%		-59.963M
-67.84%		-82.969M
-38.37%		-78.7M
5.15%		-74.692M
5.09%		-80.902M
-8.31%		N/A
27.01%		N/A
100.00%		N/AN/AN/AN/A
89.61%		N/A
389.57%		N/A
119.03%
Operating Margin
MGTA operating margin by date.MGTA operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
MGTA eps by date.MGTA eps by date.
N/AN/AN/A-2.05
49.09%		-1.74
15.12%		-1.31
24.71%		-1.29
1.53%		N/A
34.37%		N/A
102.41%		N/AN/AN/A
-4,100.00%		N/A
77.50%		N/A
361.11%		N/A
104.26%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 23 Q4 / 23
EPS
Q2Q % growth		-0.31
-13.33%		0.00
100.00%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/A
EBIT
Q2Q % growth		-18.753M
-8.69%
100.00%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MGTA Yearly Revenue VS EstimatesMGTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 50M 100M 150M 200M
MGTA Yearly EPS VS EstimatesMGTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -1 -2 -3 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
26.32%
EPS Next 5 Year
6.46%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

MAGENTA THERAPEUTICS INC / MGTA Forecast FAQ

What do analysts expect the price target to be for MAGENTA THERAPEUTICS INC (MGTA)?

6 analysts have analysed MGTA and the average price target is 1.02 USD. This implies a price increase of 45.8% is expected in the next year compared to the current price of 0.6996.

What is the next earnings date for MGTA stock?

MAGENTA THERAPEUTICS INC (MGTA) will report earnings on 2023-11-01.

Can you provide the consensus estimates for MAGENTA THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of MAGENTA THERAPEUTICS INC (MGTA) is -0.31 USD and the consensus revenue estimate is 0 USD.

Can you provide the analyst count for MAGENTA THERAPEUTICS INC stock?

The number of analysts covering MAGENTA THERAPEUTICS INC (MGTA) is 6.